Paediatric treatment issues. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Paediatric treatment issues.

Int J Clin Pract Suppl. 1999 Jun;103:26-9. Unique Identifier : AIDSLINE MED/20087920
Walters S; St Mary's Hospital Medical School, Imperial College, London, UK.


Abstract: Compared with the therapeutic options available for the treatment of HIV infection in adults, the therapeutic options available for the treatment of paediatric patients is limited. New anti-HIV agents are needed to broaden the range of effective therapeutic options. However, several factors need to be considered when treating HIV infection in paediatric patients. It is important that the antiviral combination is potent and has at least one agent with adequate CNS penetration. In addition, to aid adherence it is important that any new agent is administered once daily and that the paediatric formulation is palatable. Furthermore, a good safety profile and compatibility with other anti-HIV drugs is also important. Efavirenz has many properties that make it suitable for the treatment of HIV infection especially in paediatric patients. In addition, recent clinical evidence indicate that efavirenz will be a very useful drug for paediatric therapy.


Keywords: JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL Administration, Oral Adolescence Anti-HIV Agents/*ADMINISTRATION & DOSAGE Child Child, Preschool Clinical Trials Drug Therapy, Combination Human HIV Infections/*DRUG THERAPY HIV Protease Inhibitors/ADMINISTRATION & DOSAGE Nelfinavir/ADMINISTRATION & DOSAGE Oxazines/*ADMINISTRATION & DOSAGE

KWDjournalarticlereviewreview,tutorialadministration,oraladolescenceanti-hivagents/KWDadministration&dosagechildchild,preschoolclinicaltrialsdrugtherapy,combinationhumanhivinfections/KWDdrugtherapyhivproteaseinhibitors/administration&dosagenelfinavir/administration&dosageoxazines/KWDadministration&dosage
000430
A0040887


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .